Session proposals

Areas covered will include:

• overlapping lung disease.
• digital health interventions for the management of respiratory patients.
• adverse drug reactions and the lungs.
• beyond COVID-19 – a 360-degree view from patients, professionals and public health on life after pandemics.
• physiology and rehabilitation for COVID-19 patients.

Areas covered will include:

• long-term nasal high flow therapy: in whom and how?
• monitoring of noninvasive ventilation: what is necessary?
• preparing for the next respiratory pandemic.
• machine learning in respiratory critical care.
• technical and ethical aspects of long-term home mechanical ventilation.

Areas covered will include:

• deep phenotyping of emerging respiratory diseases using immunology, genetics and transcriptomics, and exploration of the potential longer-term implications of these diseases.
• impacts of the micro-environment and cellular repair mechanisms on the early origins of chronic lung disease.
• utilising data from single cell approaches to study existing and recently emerging lung diseases.
• novel imaging technologies for the study of respiratory molecular cell biology and lung regeneration.
• integrated data analysis, bioinformatics, digital biomarkers and systems medicine to further basic and translational lung science.
• cellular, oxidative, hypoxic, nutrient, and ER stress signalling in pulmonary disease.

Areas covered will include:

• new technologies in obstructive sleep apnoea diagnosis and treatment.
• obesity hypoventilation syndrome: new classification and treatment choice.
• obstructive sleep apnoea: residual sleepiness, cognitive impairment and fatigue from identification to treatment.
• sleep in respiratory diseases: from pathophysiology to clinical implications.
• ABCD classification of obstructive sleep apnoea: does it really works?
• telemedicine and its role in diagnosis, treatment and follow-up of sleep breathing disorders.

Areas covered will include:

• new drugs in asthma and COPD: biologics and bronchodilators.
• precision medicine in asthma and COPD.
• low-T2 inflammation; the new Everest?
• pharmacology of lung immune responses: which pathways to target?
• how should we treat asthma in 2021?

Areas covered will include:

• do genetic and environmental factors alter long term recovery from severe COVID19?
• COVID-19 and work: from historical to modern day workplace perspectives.
• highlights on gender and respiratory health: implications for research, prevention and clinical management of respiratory diseases.
• life and work post COVID-19.
• what works to prevent the uptake of nicotine and tobacco by youth: using social media and e-health approaches?

Areas covered will include:

• chronic lung inflammation and infection in children.
• management of wheeze from birth to adolescence.
• new technologies for the management of children with respiratory diseases.
• treatable traits in preschool wheeze.
• antimicrobial resistance and lung infections in children.

Areas covered will include:

• lung graft allocation and monitoring in the 21st century.
• integrating innovation and new technology into thoracic surgery.
• artificial intelligence and innovative techniques in the management of chest malignancies.
• digital health surveillance in the thoracic surgery pathway.

Areas covered will include:

• sarcopenia in chronic respiratory disease: new definitions, assessment and treatment options.
• psychosocial care in chronic lung disease: nursing issues in chronic lung care.
• fatigue and pain in COPD and other chronic respiratory diseases.
• standardisation and updates concerning pulmonary function testing and interpretation.
• allied health treatment in COVID-19: ICU, inpatient [ward] and after hospital discharge.
• safe spirometry in the in the COVID-19 area, from primary care to tertiary centre, from proven PCR negative to COVID-19 positive patients.
• post COVID-19 rehabilitation: different profiles and different settings.
• tele-rehabilitation in chronic respiratory disease and COVID-19 / using novel technologies to organise rehabilitation with video conferencing.
• rehabilitation 4–6 weeks after COVID-19 infection: how to start the rehabilitation, increase and assess the training intervention and the long-term follow-up; when, how and by whom?

Areas covered will include:

• new diagnostic approaches and treatment regimens in tuberculosis.
• managing antibiotic resistance in respiratory infection: applying the guidelines.
• late complications of COVID-19.
• comparing two WHO Global Health Emergencies: tuberculosis and COVID-19.
• respiratory infection control and evidence behind personal protective equipment.

Areas covered will include:

• advances in lung cancer sampling and molecular subtyping.
• advances in multimodal therapies in stage III non-small-cell lung carcinoma.
• advances in targeted therapy of driver addicted lung cancer.
• artificial intelligence in diagnostics and therapy of (suspected) lung cancer?
• pleural malignancies: rational diagnostics and evidence-based local and systemic therapies.

Areas covered will include:

• COVID-19 – translational medicine, pathobiology and immunology in collaboration with the molecular group.
• the effect of comorbidities in COVID-19: interstitial lung diseases before and after recovery.
• long-term follow-up of interstitial lung diseases after recovery and possible antifibrotic regimens.
• genetics and interstitial lung diseases.
• progressive fibrosing interstitial lung disease.

Areas covered will include:

• COVID-19 and pulmonary vessels: what have we learned?
• optimal follow-up after acute pulmonary embolism and long-term complications after pulmonary embolism.
• early diagnosis of pulmonary hypertension, in the context of connective tissue disease, genetic predisposition and liver disease.
• how to manage situations in pulmonary hypertension: travel, oxygen therapy, surgery, pregnancy, atrial fibrillation, chest pain?
• duration of anticoagulant thromboprophylaxis in different settings.

Areas covered will include:

• interventional pulmonology: rotation of advanced techniques simulators.
• from endosonography, cryo and valves to pleural management.
• interventional bronchoscopy board: interdisciplinary discussion of endoscopic cases.
• transthoracic ultrasound.
• correctly classifying interstitial lung diseases.